Aptevo Therapeutics Inc.
APVO$5.08▲ 1.20% 24h
$5.08
+$0.3383(+7.13%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$6.00M
P/E ratio
—
EPS (diluted)
$-87.27
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$3.11M
Net income
$-25.97M
Net margin
-833.9%
Gross margin
—
Dividends & financials
Aptevo Therapeutics Inc. (APVO) reported revenue of $3.11M and net income of $-25.97M, or $-87.27 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
